• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估来自三个地理区域的前列腺癌病例和对照个体中与 PSA 水平相关的因素。

Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.

机构信息

Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences (FMHS), University of Auckland, Private Bag 92019, Auckland, New Zealand.

Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, MD, 20892, USA.

出版信息

Sci Rep. 2022 Jan 7;12(1):55. doi: 10.1038/s41598-021-04116-8.

DOI:10.1038/s41598-021-04116-8
PMID:34997089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8742081/
Abstract

It is being debated whether prostate-specific antigen (PSA)-based screening effectively reduces prostate cancer mortality. Some of the uncertainty could be related to deficiencies in the age-based PSA cut-off thresholds used in screening. Current study considered 2779 men with prostate cancer and 1606 men without a cancer diagnosis, recruited for various studies in New Zealand, US, and Taiwan. Association of PSA with demographic, lifestyle, clinical characteristics (for cases), and the aldo-keto reductase 1C3 (AKR1C3) rs12529 genetic polymorphisms were analysed using multiple linear regression and univariate modelling. Pooled multivariable analysis of cases showed that PSA was significantly associated with demographic, lifestyle, and clinical data with an interaction between ethnicity and age further modifying the association. Pooled multivariable analysis of controls data also showed that demographic and lifestyle are significantly associated with PSA level. Independent case and control analyses indicated that factors associated with PSA were specific for each cohort. Univariate analyses showed a significant age and PSA correlation among all cases and controls except for the US-European cases while genetic stratification in cases showed variability of correlation. Data suggests that unique PSA cut-off thresholds factorized with demographics, lifestyle and genetics may be more appropriate for prostate cancer screening.

摘要

目前,人们对于基于前列腺特异性抗原(PSA)的筛查是否能有效降低前列腺癌死亡率仍存在争议。这种不确定性可能与筛查中使用的基于年龄的 PSA 截断阈值的缺陷有关。本研究共纳入了 2779 名前列腺癌患者和 1606 名无癌症诊断的男性,他们分别来自新西兰、美国和中国台湾的多项研究。采用多元线性回归和单变量模型分析了 PSA 与人口统计学、生活方式、临床特征(病例组)以及醛酮还原酶 1C3(AKR1C3)rs12529 基因多态性之间的相关性。对病例组进行的多变量合并分析显示,PSA 与人口统计学、生活方式和临床数据显著相关,种族和年龄之间的相互作用进一步改变了这种相关性。对对照组数据的多变量合并分析也表明,人口统计学和生活方式与 PSA 水平显著相关。独立的病例和对照组分析表明,与 PSA 相关的因素在每个队列中都是特定的。单变量分析显示,除了美国-欧洲病例外,所有病例和对照组的年龄和 PSA 之间均存在显著相关性,而病例中的基因分层显示相关性存在差异。数据表明,针对人口统计学、生活方式和遗传学的特定 PSA 截断阈值可能更适合前列腺癌筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a614/8742081/2da0c32ce002/41598_2021_4116_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a614/8742081/1b2d5e6de92c/41598_2021_4116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a614/8742081/572a5b1f9546/41598_2021_4116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a614/8742081/c394ffdeac6b/41598_2021_4116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a614/8742081/2da0c32ce002/41598_2021_4116_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a614/8742081/1b2d5e6de92c/41598_2021_4116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a614/8742081/572a5b1f9546/41598_2021_4116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a614/8742081/c394ffdeac6b/41598_2021_4116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a614/8742081/2da0c32ce002/41598_2021_4116_Fig4_HTML.jpg

相似文献

1
Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.评估来自三个地理区域的前列腺癌病例和对照个体中与 PSA 水平相关的因素。
Sci Rep. 2022 Jan 7;12(1):55. doi: 10.1038/s41598-021-04116-8.
2
Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand.新西兰前列腺癌队列中白细胞醛酮还原酶 1C3 活性、基因型、生物学、生活方式和临床特征之间的相互作用。
PLoS One. 2019 May 24;14(5):e0217373. doi: 10.1371/journal.pone.0217373. eCollection 2019.
3
Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts.在美纽队列中评估 aldoketo 还原酶 1C3 rs12529 多态性与生活方式和遗传变异对高危前列腺癌检测变异性的影响。
PLoS One. 2018 Jun 19;13(6):e0199122. doi: 10.1371/journal.pone.0199122. eCollection 2018.
4
Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?新西兰前列腺癌队列中雄激素剥夺治疗对生活质量的影响:我们能否基于醛糖还原酶家族1成员C3 rs12529基因多态性进行分层以将影响降至最低?
BMC Urol. 2016 Aug 2;16(1):48. doi: 10.1186/s12894-016-0164-4.
5
Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review.醛酮还原酶 1C3 在前列腺癌中的作用——小型综述。
Curr Cancer Drug Targets. 2017;17(7):603-616. doi: 10.2174/1568009617666170330115722.
6
A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).在一项基于人群且有组织地进行前列腺特异性抗原筛查的研究中,家族史作为前列腺癌风险因素的研究:瑞士前列腺癌筛查欧洲随机研究(ERSPC,阿劳)的结果
BJU Int. 2016 Apr;117(4):576-83. doi: 10.1111/bju.13310. Epub 2015 Oct 6.
7
Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.前列腺特异性抗原检测的应用与前列腺癌患者的死亡率。
JAMA Netw Open. 2024 Jun 3;7(6):e2414582. doi: 10.1001/jamanetworkopen.2024.14582.
8
Prostate Cancer Mortality in Men Aged 70 Years Who Recently Underwent Prostate-Specific Antigen Screening.近期接受前列腺特异性抗原筛查的70岁男性的前列腺癌死亡率
JAMA Netw Open. 2025 Feb 3;8(2):e2459766. doi: 10.1001/jamanetworkopen.2024.59766.
9
Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer.极低前列腺特异性抗原水平与高级别前列腺癌男性患者癌症特异性死亡增加的关联。
Cancer. 2016 Jan 1;122(1):78-83. doi: 10.1002/cncr.29691. Epub 2015 Sep 15.
10
Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.基于基线时多个与风险相关的单核苷酸多态性与前列腺特异性抗原的比较,预测未筛查男性的前列腺癌。
Eur Urol. 2012 Mar;61(3):471-7. doi: 10.1016/j.eururo.2011.10.047. Epub 2011 Nov 7.

引用本文的文献

1
A Case-Control Study of Association Between Serum Levels of 19 Trace Elements with Prostate Cancer in Southwest China.中国西南部血清19种微量元素水平与前列腺癌关联的病例对照研究
Biol Trace Elem Res. 2025 Mar 17. doi: 10.1007/s12011-025-04563-8.
2
Association between the use of proton pump inhibitors and serum PSA levels in the general U.S. population.美国普通人群中质子泵抑制剂的使用与血清前列腺特异性抗原水平之间的关联。
World J Urol. 2025 Feb 21;43(1):133. doi: 10.1007/s00345-025-05469-9.
3
Patient-specific prostate tumour growth simulation: a first step towards the digital twin.

本文引用的文献

1
Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.基于 1000 基因组计划推断数据的日本全基因组关联研究:日本多机构合作队列研究。
Nagoya J Med Sci. 2021 Feb;83(1):183-194. doi: 10.18999/nagjms.83.1.183.
2
Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study.影响接受根治性前列腺切除术的前列腺癌患者前列腺特异性抗原水平的临床因素:一项回顾性研究。
Future Sci OA. 2021 Jan 12;7(3):FSO643. doi: 10.2144/fsoa-2020-0154.
3
针对个体患者的前列腺肿瘤生长模拟:迈向数字孪生的第一步。
Front Physiol. 2024 Oct 30;15:1421591. doi: 10.3389/fphys.2024.1421591. eCollection 2024.
4
Mucins as Potential Biomarkers for Early Detection of Cancer.黏蛋白作为癌症早期检测的潜在生物标志物。
Cancers (Basel). 2023 Mar 7;15(6):1640. doi: 10.3390/cancers15061640.
5
Zinc in Prostate Health and Disease: A Mini Review.锌与前列腺健康和疾病:一篇综述短文
Biomedicines. 2022 Dec 10;10(12):3206. doi: 10.3390/biomedicines10123206.
6
Biomolecule-functionalized nanoformulations for prostate cancer theranostics.用于前列腺癌治疗学的生物分子功能化纳米制剂。
J Adv Res. 2023 Sep;51:197-217. doi: 10.1016/j.jare.2022.11.001. Epub 2022 Nov 9.
7
Prostate-Specific Antigen Monitoring Using Nano Zinc(II) Metal-Organic Framework-Based Optical Biosensor.基于纳米氧化锌金属有机框架的光学生物传感器用于前列腺特异性抗原监测。
Biosensors (Basel). 2022 Oct 27;12(11):931. doi: 10.3390/bios12110931.
8
The most effective but largely ignored target for prostate cancer early detection and intervention.前列腺癌早期检测和干预最有效但在很大程度上被忽视的靶点。
J Cancer. 2022 Oct 17;13(13):3463-3475. doi: 10.7150/jca.72973. eCollection 2022.
9
Environmental Exposure to Metals, Parameters of Oxidative Stress in Blood and Prostate Cancer: Results from Two Cohorts.环境金属暴露、血液氧化应激参数与前列腺癌:两个队列的研究结果
Antioxidants (Basel). 2022 Oct 18;11(10):2044. doi: 10.3390/antiox11102044.
Transcriptomic analysis of tobacco-flavored E-cigarette and menthol-flavored E-cigarette exposure in the human middle ear.
转录组分析电子烟和薄荷醇电子烟暴露对人中耳的影响
Sci Rep. 2020 Nov 27;10(1):20799. doi: 10.1038/s41598-020-77816-2.
4
Tobacco and marijuana use and their association with serum prostate-specific antigen levels among African American men in Chicago.芝加哥非裔美国男性中烟草和大麻的使用及其与血清前列腺特异性抗原水平的关联。
Prev Med Rep. 2020 Aug 11;20:101174. doi: 10.1016/j.pmedr.2020.101174. eCollection 2020 Dec.
5
Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels.全基因组关联研究鉴定出新型单核苷酸多态性,其对前列腺特异性抗原水平具有年龄特异性影响。
Prostate. 2020 Dec;80(16):1405-1412. doi: 10.1002/pros.24070. Epub 2020 Sep 11.
6
Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy.雄激素代谢基因多态性与血清睾酮水平及雄激素剥夺治疗的预后
Urol Oncol. 2020 Nov;38(11):849.e11-849.e18. doi: 10.1016/j.urolonc.2020.06.033. Epub 2020 Jul 22.
7
A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study.健康专业人员随访研究中肥胖与晚期前列腺癌风险的代谢组学分析
Metabolites. 2020 Mar 10;10(3):99. doi: 10.3390/metabo10030099.
8
Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.系统评价和荟萃分析体重指数、前列腺癌、晚期前列腺癌和前列腺特异性抗原之间的关联。
Cancer Causes Control. 2020 May;31(5):431-449. doi: 10.1007/s10552-020-01291-3. Epub 2020 Mar 11.
9
The Vitamin D Assessment (ViDA) study - Design and main findings.维生素 D 评估(ViDA)研究-设计和主要发现。
J Steroid Biochem Mol Biol. 2020 Apr;198:105562. doi: 10.1016/j.jsbmb.2019.105562. Epub 2019 Dec 3.
10
Histological differences in cancer cells, stroma, and luminal spaces strongly correlate with in vivo MRI-detectability of prostate cancer.癌细胞、基质和管腔空间的组织学差异与前列腺癌的体内 MRI 检测高度相关。
Mod Pathol. 2019 Oct;32(10):1536-1543. doi: 10.1038/s41379-019-0292-y. Epub 2019 Jun 7.